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ABSTRACT
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Alternative medicine, in the form of dietary supplements, is appealing to
Americans. Supplements have been marketed as being natural promoters of general wellbeing, healing, and disease prevention. Even with minimal regulation and research, the
majority of supplement use is self-prescribed, fueling an industry last estimated at $32.5
billion in 2012.
The study explored the degree of consumer knowledge with regards to regulation,
appropriate indications and dosages, and potential adverse effects of various dietary
supplements. The study also sought to evaluate the relationship between supplement
knowledge and demographic information as well as the extent of discussion about
supplement use with a provider, if any.
The instrument utilized was a novel survey developed by the researchers of this
study. Surveys were distributed at CHI Saint Alexius Health and Dakota Community
Bank in Bismarck, North Dakota.
Data analysis revealed a <50% knowledge level among all populations surveyed.
The extent of provider discussion was also minimal. No significant relationship was
found between supplement users’ demographic data and their level of knowledge. Among
all groups surveyed, no significant correlation appeared to exist between their level of
knowledge and their extent of discussion with a provider.
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Chapter One: Introduction
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Introduction
More than half of American adults use dietary supplements (Bailey, Gahche,
Miller, Thomas, & Dwyer, 2013). As a result of consumers’ increased interest in
“natural” healing modalities, dietary supplements have flooded the market, many with
little scientific evidence concerning proper indications, dosages, and adverse effects.
Despite the lack of scientific evidence regarding their efficacy, United States (US)
investments in herbal supplements alone have amounted to billions of dollars, last
estimated at $32.5 billion in 2012 (Garcia-Cazarin, Wambogo, Regan, & Davis, 2014).
Further, dietary supplements have little regulation, so consumers cannot always be sure
they get what they pay for.
The study analyzed supplement users’ level of knowledge regarding the
regulation of dietary supplements as well as proper indications, appropriate dosages, and
potential risks associated with dietary supplements. The study also analyzed the extent of
patient-provider communication regarding dietary supplements.
Background
The majority of supplement use in the US is self-prescribed (Thompson &
Nichter, 2007). Many people receive their information regarding supplements from the
media. In a survey conducted by Marinac et al (2007), 75% of people reported having
heard information related to dietary supplements within the last month. In that study,
73% of people reported a television source, 30% reported magazine and radio sources,
13% reported newspaper sources, eight percent reported friends, and five percent
reported store displays.

Vitamin and herbal supplements are widely used by the US population for
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reported reasons such as promoting good health, alleviating arthritis, improving memory,
and prophylaxis for colds and osteoporosis (Kaufman, Kelly, Rosenberg, Anderson, &
Mitchell, 2002). A small percentage of users report that they either do not know why they
take supplements or that they take supplements for no reason (Kaufman et al., 2002).
Further, some consumers purchase dietary supplements as a means of delaying
unaffordable medical care (Avogo, 2008), but this approach may be less cost-effective
than they imagine. Additionally, some persons’ usage of herbal medicine stems from
their dissatisfaction with the effectiveness and safety of conventional allopathic
medicines (Alissa, 2014).
While there is a wealth of evidence that dietary supplements are effective in
preventing and treating nutritional deficiencies, little evidence exists regarding their
efficacy in preventing or treating diseases (National Institutes of Health [NIH], 2012).
Consumer willingness to take a dietary supplement is perhaps compounded by the
perception that products derived from natural sources means those products are pure and
not harmful (Kaptchuk & Eisenberg, 1998). However, in the realm of dietary
supplements, natural does not mean safe. (NIH, 2012). Potential risks are involved with
supplement use, including adverse reactions from excessive doses and prescription drug
interactions.
Excessive dosage of dietary supplements has both health and financial
implications. For example, excessive Vitamin D intake has been associated with
anorexia, weight loss, heart arrhythmias, and even hypercalcemia, which can put
consumers at increased risk for damage to the heart, blood vessels, and kidneys (NIH,
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2012). In other cases, excessive doses of certain vitamins or minerals are simply excreted
from the body, thereby providing no effect. Thus, it is neither medically beneficial nor

cost-effective to take dietary supplements without education regarding one’s current body
stores (especially in the case of Vitamin D) or appropriate dosing.
The US Food and Drug Administration (FDA) does not strictly regulate herbs and
supplements. Although the manufacturing facilities are registered and inspected by the
FDA, dietary supplement manufacturers are not required to demonstrate safety or
efficacy of their products before they are sold to consumers, as per the Dietary
Supplement Health and Education Act passed by Congress in 1994 (Ventola, 2010). The
lack of regulation and standardization results in variability in safety, quality, purity, and
potency of supplements (Kunle, Egharevba, & Ahmadu, 2012). For example, the
pharmacologic activity of a plant can vary according to where it was grown, when it was
harvested, and how it was stored (Crone & Wise, 1998). Researchers have reported that
measured levels of compound concentration in dietary supplements varied and did not
match labeled concentrations. Additionally, pharmacologic activity cannot be guaranteed
(Harkey, 2001).
As herbs are considered pharmacologically active compounds, concerns exist
regarding adverse effects and interactions with prescription and nonprescription
pharmaceuticals (Alissa, 2014). For example, St. John’s wort is used to treat mild to
moderate depression but has been shown to inhibit cytochrome P450 (CYP) enzymes as
well as contribute to serotonin syndrome when used with other serotonergic drugs (Shi &
Klotz, 2012). Clinical studies have shown interaction of St. John’s wort with imatinib,
warfarin, voriconazole, buspirone, omeprazole, tacrolimus, and simvastatin, among many

others (Shi & Klotz, 2012). Therefore, clinicians must inquire about patients’ use of
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dietary supplements, especially those receiving cardiovascular, immunosuppressant, or
antiretroviral therapy (Alissa, 2014).
Unfortunately, most patients do not discuss their usage of alternative medicine
with their physicians. In one survey (Eisenberg et al., 2001), over half of patients either
did not believe it was important for their physician to know of their supplement use or
reported that their physician never asked. Nearly a third believed that their use of
alternative medicine was not the physician’s business, and some believed that the
physician would not understand their reasons for supplement use (Eisenberg et al., 2001).
In another survey of primary care physicians (Tarn et al., 2014), of all conversations
regarding supplement use in the office, only 28% included how to take the supplement,
17% discussed potential risks, and 17% discussed efficacy. The study conducted by Tarn
et al. (2014) concluded that it is likely that more provider-patient communication is
needed to adequately inform patient decisions about supplement use.
Of the extensive number of herbal and dietary supplements available, many are taken
without definitive scientific evidence for efficacy and safety. The following list of
supplements (to be used in this study) was curated based on popularity as established by
the literature review. A spectrum of supplements was chosen, from commonly-used
Vitamin D to less popular cinnamon. In choosing both widely used and less frequently
used supplements, consumer knowledge regarding both necessity and appropriate use of
each will be tested. The supplements in this study include the following:
1. Vitamin D
2. Conezyme Q10 (CoQ10)

3. Fish oil
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4. Garlic
5. St. John’s wort
6. Cinnamon
7. Magnesium
Vitamin D, fish oil, and St. John’s wort were chosen because they are popular yet
pose potential threats. Excess Vitamin D intake can be toxic (Pazirandeh & Burns, 2014).
Fish oil may increase bleeding risk and decrease immunity (Zelig & Rigassio-Radler,
2012), while St. John’s wort has potential drug interactions (Shi & Klotz, 2012). Garlic
and CoQ10 also pose risks for consumers. Garlic can thin the blood, and CoQ10 can both
lower blood pressure and increase clotting (Zelig & Rigassio-Radler, 2012). Cinnamon is
commonly self-prescribed to prevent insulin resistance and decrease inflammation;
however, evidence shows that cinnamon does not prevent exacerbation of metabolic
disorders (Soare, Weiss, Holloszy, & Fontana, 2014). Excess magnesium intake has
serious risks, including hypotension, urine retention, depression, arrhythmias, and cardiac
arrest (Musso, 2009).
Problem Statement
Dietary supplements are easily accessible and widely used by American
consumers. Often, supplements are consumed with scant evidence regarding appropriate
indications and efficacy. Supplements are also consumed without sufficient knowledge
regarding potential side effects and risks. Finally, supplement use is seldom discussed
with healthcare providers. Consumers must be aware of the potential risks of supplement
use as well as appropriate supplement indications and dosages. Consumers must discuss

their interest in supplements with a healthcare provider before usage, especially those
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consumers concurrently taking prescription medications. Further, providers must educate
themselves regarding dietary supplements so they are able to appropriately advise their
patients.
Purpose of the Study
The purpose of this study was to determine whether consumers of dietary
supplements are knowledgeable regarding FDA regulation of dietary supplements,
appropriate indications, and any potential risks involved with dietary supplement
consumption, including drug interactions. The study also established how consumers
determine their supplement dosages and what aspects of supplement use, if any, were
discussed with their healthcare provider.
Significance of the Study
The study has significance for both potential and current dietary supplement
consumers as well as both aspiring and current healthcare practitioners. Consumers may
use the study as a means of self-education in terms of indications and risks related to
dietary supplement use. Further, the study may encourage patients to discuss their
supplement use with clinicians.
The study also establishes a platform for providers to discuss supplement use with
their patients during routine physicals. It may also prompt providers to further research
dietary supplements to increase their own level of understanding regarding the
indications, appropriate dosages, benefits, and risks of dietary supplements.
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Finally, the findings from the study may prompt further research into the efficacy,
appropriate dosage and duration, and potential risks (side effects, drug interactions)
related to dietary supplements.
Research Questions
To gain insight concerning dietary supplement use of surveyed populations, the
research instrument (survey) was designed to answer the following inquiries:
1. To what degree, if any, are supplement users knowledgeable regarding the
regulation, appropriate indications and dosages (as determined by literature
review), and potential adverse effects of dietary supplement use? What
relationship, if any, exists between supplement users’ demographic data and their
knowledge of the aforementioned factors?
2. To what extent, if any, do supplement users discuss their dietary supplement
use with healthcare providers? What relationship, if any, exists between
supplement users’ level of knowledge regarding dietary supplements and their
extent of discussion of dietary supplements with healthcare providers?
Definitions
Dietary supplements: Dietary supplements are defined by the FDA as products
that contain one or more of the following: a vitamin, a mineral, an herb or other
botanical, an amino acid, a substance to supplement the diet by increasing the total
dietary intake, and/or a concentrate, metabolite, constituent, or extract (FDA, 2016).
Supplement use: Participants were asked to report data regarding supplements
they currently took at the time of the survey.

Healthcare provider: The healthcare provider will be defined as a certified
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Physician Assistant (PA-C), Nurse Practitioner (NP), Medical Doctor (MD), or Doctor of
Osteopathy (DO) in any specialty.
Knowledgeable: Whether survey participants were considered knowledgeable
regarding supplement use was determined by their overall survey score for all of the
supplements they take. The survey instrument was comprised of questions that did have
correct answers; the more questions a respondent answered correctly, the more
knowledgeable he or she was considered regarding that supplement.
Summary
Dietary supplements are easily accessible and widely used by American
consumers. Despite the evidence that they are effective for treating nutritional
deficiencies, little evidence exists regarding their efficacy in treating other diseases.
Supplement users, especially those taking prescription medications, must be aware of
their potential side effects as well as drug interactions. They must also be aware of
appropriate dosages, as excess supplement concentrations either provide no benefit or
cause harmful side effects. Supplement users must discuss their consumption with their
healthcare providers before beginning a regimen.
The study assessed consumers’ knowledge level regarding appropriate indications
and potential risks of dietary supplement use. The study also evaluated the degree to
which consumers discuss their dietary supplement use with their healthcare providers.

Chapter 2: Literature Review
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Introduction
The following literature review will consist of a history of dietary supplements,
current regulation practices for the manufacturing and monitoring of dietary supplements,
consumer knowledge regarding regulation, common sources of information for
supplement consumers, and the extent of provider-patient communication regarding
supplement use. The literature review will also present information regarding indications,
efficacy, appropriate dosages, and adverse effects of the supplements to be included in
the study. Current research lacks adequate long-term randomized controlled trials
studying the efficacy of supplements for commonly reported indications. Further, little
research exists regarding consumers’ multi-faceted level of knowledge regarding dietary
supplements, including their regulation, indications, appropriate dosages, and potential
adverse effects.
History of Dietary Supplements
Herbal medicine is regarded as the oldest form of healthcare and has been
historically used in all cultures (Barnes, Anderson, & Phillipson, 2007). Physical
evidence for early herbal use dates back to 60,000 B.C. with Neanderthals (Solecki,
1975). Throughout history, humans have relied on nature for health, using plants as a
resource for food, clothing, shelter, and medicine. By trial and error, early humans
distinguished ineffective or harmful plants from those with beneficial effects and
developed methods of processing and combining plants to yield optimal results (Kunle,
Egharevba, & Ahmadu, 2012).

Knowledge of herbal medicine passed on through millennia has become the
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knowledge base for today’s traditional medicine. In fact, herbs are still the most central
form of medicine in some communities, which may be due to poverty and inaccessibility
to modern medicine (Kunle et al., 2012).
Today, dietary supplements are legally defined as products that are intended to
supplement the diet. They are distinguished from pharmaceuticals in that they are not
intended to prevent, diagnose, treat, mitigate, or cure diseases (Bailey et al., 2013).
Dietary supplements include vitamins, minerals, herbs, amino acids, extracts,
concentrates, and metabolites (FDA, 2016).
Regulation of Dietary Supplements
The Dietary Supplement Health and Education Act (DSHEA) of 1994 claimed
dietary supplements were neither food nor drug and thereby allowed manufacturers to sell
dietary supplements without evidence of safety or efficacy (Ashar & Rowland-Seymour,
2008). Consequently, companies are not required to determine potential side effects or
drug-supplement interactions (Alissa, 2014).
Compounding the concerns regarding safety and efficacy of dietary supplements
is the questionable purity and potency of those products. The difficulty of standardizing
purity and potency of supplements stems from the source of the supplements. Variability
exists in the source and quality of the plants due to differences in climate and soil
composition as well as diverse conditions during preparation, storage, and transport
(Alissa, 2014; Kunle et al., 2012).
In 2007, the FDA ruled that dietary supplement manufacturers are required to
follow Good Manufacturing Practices (GMP) (Ashar, Miller, Pichard, Levine, & Wright,

2008), or pharmaceutical-grade production practices, to ensure products are
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unadulterated, properly labeled, and have consistent identity, purity, strength, and
composition (FDA, 2014). Although the FDA performs audits to ensure the conduction of
GMP, it does not test supplements before they are sold. However, supplement
manufacturers can send their products to be tested for purity and potency. Those marked
with the seals of the National Safety Foundation (NSF) or United States Pharmacopeia
(USP) have undergone this testing and should be recommended over supplements with no
such seals (Ashar et al., 2008).
Marketing of Dietary Supplements
The FDA allows structure/function claims on the labels of dietary supplements
but forbids the inclusion of health claims without FDA approval. A structure/function
claim describes the role of a product in maintaining the structure or function of the body,
while health claims describe the effect of the product on disease prevention (FDA, 2013).
Manufacturers must include on the label a disclosure that the product is not intended to
treat, prevent, or cure specific diseases (Denham, 2011).
Manufacturers are allowed, however, to imply health benefits in the titles of their
products (for example, “Cold-Away” and “Migraine-B-Gone”) (Peterson, 2014).
Consequently, consumers often interpret the structure/function claims as “thinly veiled
health and disease claims” (Thompson & Nichter, 2007), which can result in the
replacement of medications that have been thoroughly tested for safety and efficacy
(Denham, 2011).
Despite the regulation of claims, dietary supplement companies often market their
products as drugs. In 2010, the Government Accountability Office (GOA) performed an
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audit of online retailers and gathered claims of dietary supplements “treating, preventing,
and curing conditions such as diabetes, cancer, and cardiovascular disease” (Denham,
2011). One retailer suggested garlic supplements could replace hypertension medication,
while another stated ginkgo biloba could treat Alzheimer’s disease, depression, and
impotence (Denham, 2011).

Finally, many consumers are unaware of the regulation practices regarding dietary
supplements. In one survey in which participants were shown an advertisement for a
dietary supplement, 52% were unaware that the FDA did not test the supplement for
safety or efficacy (Ashar & Rowland, 2008).
Dietary Supplement Consumer Profile
Currently about half of American adults report using one or more dietary
supplements (Bailey et al., 2013). These American consumers are often Caucasian, welleducated, and employed. A large proportion of these individuals are young to middleaged females and are aware of the importance of a healthy lifestyle (Crone & Wise,
1998). Use among ethnic populations is typically associated with cultural beliefs and/or
practices (Crone & Wise, 1998).
Consumers are inundated with information regarding dietary supplements. In one
survey (Marinac et al., 2007), 75% of people reported having heard information related to
dietary supplements within the last month. In that study, 73% of people reported a
television source, 30% reported magazine and radio sources, 13% reported newspaper
sources, eight percent reported friends, and five percent reported store displays (Marinac
et al., 2007). In a qualitative study conducted by Thompson and Nichter, 20% of
surveyed participants reported being skeptical of printed sources of information regarding

dietary supplements, while 35% trusted information from friends and family, and 23%
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credited their own “experimental” use as the most important factor in determining
whether to take (and how to take) a supplement (Thompson & Nichter, 2007).
Consumer-Reported Indications for Dietary Supplement Use
Those who are dissatisfied with or those who cannot access conventional
medicine are more likely to use supplements (Avogo, 2008). Such practices are especially
prevalent in patients with chronic conditions or life-threatening prognoses such as cancer,
human immunodeficiency virus (HIV), Alzheimer’s disease, and chronic fatigue
syndrome; herbal medicines become attractive when conventional medicine fails to yield
the desired outcome (Crone & Wise, 1998).
Consumers are enamored by the language of alternative medicine, as it sounds
person friendly and holistic (Kaptchuk & Eisenberg, 1998). Consumers often cite the
natural healing effects of dietary supplements as reasons for their use; supplements are
presumed to be safer and more mild than pharmaceuticals (Ashar et al., 2008).
Supplements are easily accessible and often inexpensive and provide a means for
consumers to be proactive regarding their health; in fact, many consumers believe
supplements have curative effects that can be obtained without the hassle of healthcare
appointments, lifestyle changes, and/or procedures (Ashar et al., 2008).
Many of the most commonly reported reasons for supplement use are more likely
to be driven by individual perceptions of efficacy than by scientific evidence of efficacy
(Blendon, Benson, Botta, & Weldon, 2013). Consumers most commonly report dietary
supplement use to “improve” (45%) or “maintain” (33%) their overall health (Bailey et
al., 2013). Though the National Institutes of Health (NIH) currently recommends dietary

supplement use only for alleviating nutritional deficiencies (NIH, 2012), only 22% of
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supplement users cite this as their primary reason for consuming supplements (Bailey et
al., 2013). Further, a small percentage of consumers report that they do not know why
they are taking supplements (Kaufman et al., 2002).
Supplement Efficacy
Little research exists regarding the efficacy of dietary supplements for disease
prevention, management, or treatment in well-nourished populations (Bailey et al., 2013).
Studies measuring specific health parameters (such as blood pressure) have been too
short in duration to obtain information on primary outcomes for conditions such as cancer
and heart disease (Bailey et al., 2013).
Bailey et al. conclude that the epidemiologic study of supplement use in disease
prevention and health promotion is rendered difficult by the inability to disentangle
supplement use from other health-seeking behaviors (Bailey et al., 2013). However,
further trials studying the safety and efficacy of dietary supplements may not
dramatically impact the industry. In a study by Blendon et al., 75% of dietary supplement
users claimed they would be “minimally influenced by government statements
contradicting the efficacy claims of supplement manufacturers” (Blendon et al., 2013).
Consumers’ beliefs in self-prescribed vitamins are “unshakable” and solidified by skewed
perceptions of scientific facts while contrary evidence is overlooked (Apple, 1996).
Appropriate Dosage and Adverse Effects of Supplements
The literature contains a vast amount of evidence regarding pharmacologic
activity in dietary supplements as well as potential interactions when taken with
prescription medications (Alissa, 2014).

The combined use of dietary supplements and drugs may increase or reduce the
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effects of either by affecting pharmacokinetics and/or pharmacodynamics (Alissa, 2014).
Synergistic effects may lead to toxicity by affecting organ systems, receptor sites, and
enzymes (Alissa, 2014), while antagonistic effects may lead to reduced efficacy and
therapeutic failure (Hu et al., 2005). The risk for drug interactions also increases with the
number of products (drugs and supplements) consumed (Alissa, 2014).
Marinac et al. (2007) suggested that dietary supplement consumers may be
unaware of potential adverse drug reactions. Their research concluded that 66% of people
believed that dietary supplements “pose no risk to the general population” (Marinac et al.,
2007). However, in this same survey, 12 dietary supplement consumers had potential
drug interactions. Two participants were taking garlic along with aspirin, despite
evidence that garlic poses an increased bleeding risk, and five were taking gingko biloba,
known to have anti-platelet and anticoagulant effects, along with aspirin or non-steroidal
anti-inflammatory drugs (NSAIDs).
Some dietary supplements can also cause toxicity when consumed in excess, as
reviewed below. In one study, 23% of consumers tailored their supplement regimens
experimentally or essentially viewed the suggested dosages on the labels as general
guidelines and consumed more or less as they deemed necessary (Thomspon & Nichter,
2007).
Supplement Review
The following paragraphs summarize current literature regarding indications,
appropriate dosages, and potential adverse reactions of the supplements in the study. The
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discussion regarding the choice of these particular supplements can be found in Chapter
1.
Vitamin D. Vitamin D is a fat-soluble vitamin synthesized by the body and

provided by very few foods. It requires several enzymatic conversions to the active form
for use. Vitamin D is involved in calcium homeostasis and bone metabolism and is
therefore considered necessary for good health (Pazirandeh & Burns, 2014; Bikle, 2012).
It functions to promote enterocyte differentiation and intestinal calcium absorption. Other
actions include some promotion of intestinal phosphate absorption, suppression of
parathyroid hormone release, regulation of osteoblast function, and bone resorption
(Pazirandeh & Burns, 2014).
The Institute of Medicine (IOM) set recommendations for vitamin D intake based
on the beneficial effects of calcium and vitamin D on skeletal health (IOM, 1997). The
recommended daily allowance per the IOM for persons ages one-70 is 600 international
units (IU) or 15 micrograms (mcg) daily. For adults over 70 years of age, the
recommended daily dose is 800 IU (20 mcg). Intake can be dietary or supplemental. As
dermal synthesis of vitamin D varies by individual and environment, the IOM assumed
minimal sun exposure.
A tolerable upper level intake (UL) as defined by the IOM is the maximum level
at which toxic effects are unlikely to occur. The UL for vitamin D, is 4,000 IU (100 mcg)
for children ages nine-18, healthy adults, and pregnant and lactating women.
Toxicity usually occurs after inappropriate intake, often in fad dieters consuming
“megadoses” or in those on vitamin D replacement therapy. Sun exposure does not cause
toxicity (Pazirandeh & Burns, 2014). Symptoms of acute toxicity such as confusion,
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polyuria, anorexia, vomiting, and weakness result from hypercalcemia. Chronic toxicity
can cause nephrocalcinosis and bone demineralization and pain (Pazirandeh & Burns,
2014).

A study by Schwartz (2009) has shown that vitamin D interacts with atorvastatin.
By activating CYP3A, vitamin D reduces the bioavailability of atorvastatin.
Paradoxically, vitamin D also lowers low density lipoprotein (LDL) and total cholesterol
levels (Schwartz, 2009). Studies have also shown that vitamin D deficiency may be a risk
factor for the development of tuberculosis (TB) (Sheng et al., 2015). Anti-tuberculosis
drugs, namely isoniazid (INH) and rifampin (RIF) affect cytochrome P450 enzymes,
which are responsible for the hydrolysis of vitamin D. The same research has shown that
RIF alone or in combination with INH induces renal and hepatic hydroxylation of
Vitamin D, ultimately leading to elevated serum 25-hydroxyvitamin, D3, a major
metabolite.
Coenzyme Q10 (CoQ10). CoQ10 is a potent antioxidant, and reduced levels have
been reported in Parkinson’s disease. Low CoQ10 levels have also been associated with
worse heart failure outcomes, but this is more likely because low CoQ10 is a marker
rather than predictor of advanced heart failure (Dennehy & Tsourounis, 2012). CoQ10
supplement consumers have reported use for heart failure, hypertension, angina, and
Parkinson’s disease (Bailey et al., 2013).
Three studies have shown CoQ10 can reduce both systolic and diastolic blood
pressure (by 11 and seven mm Hg, respectively), but the methods of these studies,
including adequate randomization and blinding, have been questioned (Dennehy &
Tsourounis, 2012). CoQ10 has also been shown to improve ejection fraction by 3.7% in

patients not using an angiotensin converting enzyme (ACE) inhibitor (Dennehy &
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Tsourounis, 2012). CoQ10 may also have benefits in coronary artery disease and chronic
stable angina, as it has been associated with improvements in lipoprotein a, high-density
lipoprotein (HDL), exercise tolerance, and time to development of ischemic changes on
stress testing (Dennehy & Tsourounis, 2012).
Adverse effects of CoQ10 supplements are rare. Less than 1% report
gastrointestinal (GI) upset, maculopapular rash, thrombocytopenia, irritability, dizziness,
and headache (Dennehy & Tsourounis, 2012). CoQ10 is structurally similar to vitamin K
and can therefore interfere with warfarin and decrease the international normalized ratio
(INR), so those on warfarin should avoid CoQ10 supplements or be carefully monitored
(Dennehy & Tsourounis, 2012). A daily dosage of 30 milligrams (mg) is adequate, but
studies have suggested 100-600 mg/day may be needed for cardiac effects (Dennehy &
Tsourounis, 2012).
Fish oil. Fish oil is commonly taken to lower blood pressure and triglycerides and
to prevent heart disease and stroke (Zelig & Rigassio-Radler, 2012). Systolic blood
pressure reduction by two mm Hg has been estimated to cause a 10% lower stroke
mortality. Diastolic blood pressure reduction by five mm Hg can reduce the risk of stroke
by about one third and coronary heart disease by one fifth (Campbell, Dickinson,
Critchley, Ford, & Bradburn, 2013).
In addition to lowering blood pressure, fish oil may also reduce arterial stiffness.
Reducing both the hypertension and vessel stiffness risk factors, which are associated
with cognitive decline, may benefit heart and brain health (Pase et al., 2015). Some have

suggested that cognitive benefits stem from improved cardiovascular health; others
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suggest improved cerebral perfusion and blood-brain barrier integrity (Pase et al., 2015).
Pase et al. (2015) sought to determine the effects of fish oil on cognitive function
in terms of reaction time, cognitive processing speed, short-term memory, and visual
memory. Other goals included determining fish oil effects on aortic stiffness, aortic blood
pressure, and red blood cell fatty acid levels. These researchers showed that the
treatments had no effect on primary cognitive endpoints but noted that increases in
omega-3/6 ratio were associated only with improved spacial working memory response
time. Those subjects receiving six g of daily fish oil had a reduction in aortic pulse
pressure and aortic augmentation pressure. These vascular effects were not associated
with consistent improvements in cognitive performance.
Campbell et al. performed three meta-analyses which found small, statistically
significant reductions in both systolic blood pressure (two to four mm Hg) and diastolic
blood pressure (two–2.51 mm Hg) among hypertensive fish oil consumers (Campbell et
al., 2013). The meta-analysis did not show statistically significant blood pressure
reduction in normotensive patients. Campbell’s study concluded that, given the modest
blood pressure effects of fish oil, treatment with pharmaceuticals approved for
hypertension is recommended (Campbell et al., 2013). Further, Bailey et al. performed
two meta-analyses that found fish oil supplementation had little or no benefit in
preventing the risk of major cardiovascular disease events or all-cause mortality (Bailey
et al., 2013).
Fish oil supplements are generally well tolerated (Zelig & Rigassio-Radler, 2012).
However, excess intake may result in immunosuppression, prolonged bleeding time, and

increased risk of hemorrhagic stroke. Thus, patients at increased risk for infection or
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those taking immunosuppressives, warfarin, or aspirin should consult with a physician
before consumption (Zelig & Rigassio-Radler, 2012). No current data establishes a safe
upper limit, but the FDA has endorsed up to two grams (g)/day from a dietary supplement
FDA, 2004). The general recommended daily intake is 500 mg (Opperman, 2013).
Garlic. Garlic is commonly used by individuals with hypertension, high
cholesterol, and heart disease (Zelig & Rigassio-Radler, 2012). Garlic has also been
reported to have immune-enhancing and antimicrobial effects and is therefore commonly
used by HIV patients to prevent opportunistic infections (Hu et al., 2005). For potential
benefits, garlic supplements should contain 1.3% alliin or have alliin-generating potential
of 0.6%.
Cumulative data regarding the efficacy of garlic shows the herb can improve total
cholesterol and triglycerides but not high-density lipoprotein (HDL) or low-density
lipoprotein (LDL). However, it may not reduce cholesterol to a clinically significant
extent (Dennehy & Tsourounis, 2012). Studies also show garlic has anti-platelet effects
and can work as a fibrinolytic agonist. Thus, garlic may provide benefit in those with
atherosclerosis (Dennehy & Tsourounis, 2012). The antimicrobial effect of garlic is not
well studied, so its usefulness is limited, especially due to the availability of effective
antimicrobial agents (Dennehy & Tsourounis, 2012).
Adverse effects associated with garlic consumption include GI upset, allergic
reactions, hypotension, and bleeding. Breath and body odor are reported by 20-40% of
garlic supplement consumers (Dennehy & Tsourounis, 2012). Due to its anti-platelet
effects, garlic should be avoided or used cautiously by patients taking warfarin,

ibuprofen, and aspirin (Zelig & Rigassio-Radler, 2012). Garlic has also been shown to
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decrease the serum concentration of saquinavir, an anti-viral HIV drug (Hu et al., 2005).
A dosage of 600-900 mg/day is common for powdered garlic; this is equivalent to
one fresh garlic clove per day. (Dennehy & Tsourounis, 2012).
St. John’s Wort. St. John’s wort is commonly taken to alleviate depression and
has been shown to be more efficacious than placebo and equivalent to low-dose
antidepressants in the treatment of mild to moderate depression (Dennehy & Tsourounis,
2012).
The herb, however, has some serious adverse effects, including mania, anxiety,
and insomnia (Peterson, 2014). It can also cause photosensitization, so consumers should
be advised to wear sunscreen and eye protection (Dennehy & Tsourounis, 2012). St.
John’s wort should not be used by pregnant or lactating women, as it may induce abortion
and cause lethargy in infants (Peterson, 2014).
St. John’s wort also has various potential drug interactions, as it induces many
CYP enzymes (3A4, 2C9, 1A2) and P-glycoprotein (Dennehy & Tsourounis, 2012). St.
John’s wort has been shown to decrease the levels of warfarin, statins (Ashar et al.,
2008), tacrolimus, cyclosporine, (Hu et al., 2005), oral contraceptives, HIV protease and
non-nucleotide reverse transcriptase inhibitors, theophylline, and anticonvulsants
(Dennehy & Tsourounis, 2012). Because it potentially inhibits neurotransmitter uptake, it
should not be taken with drugs with a similar mechanism of action, including
antidepressants and stimulants, due to the risk of serotonin syndrome (Dennehy &
Tsourounis, 2012).
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The appropriate dosage for antidepressive effects is 900 mg daily. St. John’s wort
may take two to four weeks for effect, and effects beyond 12 weeks have not been
studied (Dennehy & Tsourounis, 2012).
Cinnamon. Often used as a spice, cinnamon has also been used to treat
headaches, dyspepsia, wounds, inflammation, nausea, and diarrhea (Natural Medicines
Comprehensive Database [NMCD]). Cinnamon has been considered a natural treatment
for type two diabetes by controlling blood glucose levels, but randomized controlled
trials have shown no significant difference in hemoglobin A1c or serum insulin levels

between cinnamon and placebo groups (Delahanty & McCulloch, 2014; Leach & Kumar,
2012).
Cassia cinnamon, a specific type of cinnamon used in some supplements, contains
coumarin, which is a hepatotoxic compound (Ballin & Sorensen, 2014). Coumarin doses
of 50-700 mg have been known to cause reversible hepatotoxicity (Howard & White,
2013).
The NMCD considers cinnamon intake to be safe if the dosage remains within the
one to six g/day range. Long-term intake of high doses is potentially unsafe (Howard &
White, 2013). Although hepatotoxicity is unlikely with the recommended supplement
dosage, concern still exists due to the coumarin content, especially in those at risk for
liver disease (NMCD, 2014).
Regarding drug interactions, a case report analyzed by Brancheau, Patel, and
Zughaib (2015) demonstrated the risk of hepatotoxicity when cinnamon is taken
concomitantly with a statin (Brancheau et al., 2015).
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Magnesium. Magnesium is an intracellular cation that is essential for enzymatic
functions, deoxyribonucleic acid (DNA) transcription and replication, messenger
ribonucleic acid (mRNA) translation, bioelectric-activity, ionic pumps, and calciumchannel function.

Normal magnesium body content is about 22.6 g, 50%-60% of which is stored in
the bone (Musso, 2009). The recommended magnesium intake for adults is
approximately 420 mg/day for men and 320 mg/day for women (Musso, 2009).
Magnesium is clinically used to treat asthma, pre-eclampsia, and coronary
arteriopathy (Musso, 2009). In the form of supplements, magnesium can be used to treat
mild cases of hypomagnesemia but may cause diarrhea (Musso, 2009).
Symptomatic hypermagnesemia due to excessive intake occurs when serum
magnesium levels exceed four to six mg/deciliter (Musso, 2009). Toxicity can manifest
as hypotension, nausea, vomiting, facial flushing, urinary retention, ileus, depression, and
lethargy. In severe cases, symptoms can progress to flaccid skeletal muscular paralysis,
hyporeflexia, bradyarrhythmia, respiratory depression, and cardiac arrest (Musso, 2009).
Magnesium has various types of interactions with many classes of medications.
Decreased drug effectiveness is seen with allopurinol, aspirin, azithromycin, cefdinir,
ciprofloxacin, levofloxacin, doxycycline, fexofenadine, gabapentin, iron, levothyroxine,
sucrasulfate, and tetracycline (Yetley, 2007). Decreased plasma drug concentration has
been noted with digoxin and atazanavir (Yetley, 2007). Increased risk of bleeding has
been noted with succinylcholine and vecuronium and increased risk of adverse drug
effects with dicumarol (Yetley, 2007). Hypotension may occur with felodipine (Yetley,

2007). The risk of QT prolongation is also increased with levomethadyl, and increased
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serum drug levels have been noted with tacrolimus (Yetley, 2007).
Provider-Patient Communication
Most dietary supplement consumers use supplements by personal choice (77%)
rather than due to the advice of their healthcare provider (23%) (Bailey et al., 2013).
Additionally, national surveys have shown that approximately 40% of adults typically do
not disclose their use of alternative medicine to their physicians (Eisenberg et al., 2001).
Of these adults, 60% agreed to both statements “it is not important for the doctor to
know” and “the doctor never asked” (Eisenberg et al., 2001). About a third felt that
alternative medicine use was “none of the doctor’s business” and/or that “the doctor
would not understand,” while 14% expressed concern that their physician would
“disapprove of” or “discourage” their alternative medicine use (Eisenberg et al., 2001).
Two percent felt their doctor would discontinue being their provider (Eisenberg et al.,
2001).
Patients seek reliable information about supplements amidst many confusing
claims, and they desire a partnership with their clinicians, who they hope are
knowledgeable about dietary supplements and general nutrition (Eliason, Huebner, &
Marchand, 1999). Patients have reported the best conversations with clinicians regarding
alternative medicine were those in which the provider had a sense of ambivalence and
told the patient to continue using a supplement if the patient was comfortable with it
(Eliason et al., 1999).
Clinicians should be aware of available resources, including web databases and
clinical pharmacists, that can assist in protecting patients from potential adverse effects.
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Clinicians should also monitor for physiologic response to dietary supplements (Ashar et
al., 2008). Response, or lack thereof, should be discussed with patients so they can make
an informed decision to continue taking the same supplement, try a different brand, or
abandon its use altogether (Ashar et al., 2008).
Summary

Dietary supplements are currently used by over half of Americans despite the lack
of adequate scientific evidence regarding efficacy. Most dietary supplement users acquire
information regarding supplements from media and lay sources (friends and family)
rather than from healthcare providers or published clinical trials. Further, most do not
disclose their supplement use to their healthcare providers. Many commonly used
supplements may interact with drugs, especially anti-platelet and anticoagulation
medications.
The study served to elucidate the gaps in knowledge of dietary supplement
consumers regarding regulation practices, appropriate indications, and potential adverse
effects. The study may also prompt clinicians to encourage their patients to disclose
alternative medicine practices as well as offer nonjudgmental education and advice.

Chapter Three: Methods
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Introduction
The purpose of the study was to determine whether consumers of dietary
supplements are knowledgeable regarding FDA regulation of dietary supplements and
appropriate indications and any potential risks involved with dietary supplement
consumption, including drug interactions. The study also sought to establish how
consumers determine their supplement dosages and what aspects of supplement use, if
any, were discussed with their healthcare provider. The research questions addressed in
the study included the following:
1. To what degree, if any, are supplement users knowledgeable regarding the
regulation, appropriate indications and dosages (as determined by literature
review), and potential adverse effects of dietary supplement use? What
relationship, if any, exists between supplement users’ demographic data and their
knowledge of the aforementioned factors?
2. To what extent, if any, do supplement users discuss their dietary supplement
use with healthcare providers? What relationship, if any, exists between
supplement users’ level of knowledge regarding dietary supplements and their
extent of discussion of dietary supplements with healthcare providers?
The purpose of this chapter is to discuss the methods used to conduct the research
project. The following sections will be covered in this chapter: study design, study site,
sample population, instrumentation and procedure, data analysis, reliability and validity,
dispensation of data, and limitations and delimitations regarding the study.

Study Design
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The study design was pre-experimental; more specifically, it was a one-shot case
study. In a one-shot case study, a group of respondents is identified based on pre-existing
criteria, in this case, supplement use. Respondents were administered a packet which
included a survey informed consent form (Appendix A), survey instructions (Appendix
B), and the survey (Appendix C). Hospital laboratory staff and bank employees
distributed surveys to potential participants, asking them to complete and return the
packet. No treatment was imposed on the subjects, nor were any other measurements
taken.
Study Site
The surveys were distributed at CHI St. Alexius Health outpatient laboratory in
Bismarck, North Dakota. A letter of intent for research affiliation with CHI St. Alexius
Health can be found in Appendix D. Surveys were also distributed to customers of
Dakota Community Bank and Trust in Bismarck, North Dakota. A letter of intent for
research affiliation with this institution can be found in Appendix E.
Population
Participants were required to be age eighteen or greater and could be either gender
and any ethnicity. The survey was available to all consumers age eighteen or greater but
was completed on a voluntary basis.
Inclusion criteria included consumers who were current supplement users, ages
eighteen or greater. The survey instructions served to clarify the list of supplements about
which participants were asked. The instructions stated that if the participant did not
currently take any of the listed supplements, he/she was not eligible for the study.
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Therefore, criteria for exclusion were those consumers who did not currently take any of
the listed supplements at the time of the survey as well as those who did not fully
complete the survey. However, survey questions regarding supplements not taken by the

participant could be left unanswered; as long as the participant answered all the questions
pertaining to at least one supplement that he/she currently took, his/her survey was
scored.
In order to detect a meaningful difference with a standard deviation of two, at
least 20 subjects were needed for each group analyzed (see Data Analysis, page 29).
Because ANOVA was utilized to analyze differences among respondents with different
levels of education, three groups were required, so at least 60 participants were needed.
Therefore, the researchers of the study had a goal sample size of 75 completed surveys.
Instrument and Procedure
The study’s researchers developed the survey tool; no previously developed
instrument questions were used. The survey consent form, instructions, and instrument
were reviewed to determine whether each was understandable to the target population.
The panel of reviewers included a physician, two registered nurses, and an administrative
director, all who regularly work with the population surveyed. After review, the
documents were edited to meet all suggestions to achieve readability and
understandability. The survey layout was changed from a two-page format to the current
format that utilizes one page for each supplement, and the definition of “dose” was
included to ensure respondent comprehension of the word.
The research instrument was a survey that was distributed in a packet with an
informed consent document and instructions. Questions in the survey assessed participant
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knowledge of regulation, indications, and risks associated with specific supplements. The
survey also contained questions regarding supplement dosage and discussion of use with
a provider. The survey also collected demographic data including gender, age, and level
of education. No unique identifying information was collected, such as name, date of
birth, or contact information.
The surveys were distributed at CHI St. Alexius Health outpatient laboratory by
receptionists upon appointment check-in. Seven surveys were completed by the CHI St.
Alexius patient population over the course of eight weeks, so the researchers sought an
additional population to increase the sample size. The researchers secured an affiliation
with Dakota Community Bank and Trust in Bismarck, North Dakota. “Good Neighbor
Loyalty Club” representatives, employed by the bank, distributed the surveys to senior
travel club members during a bus trip. See Appendix F for this research addendum. The
researchers of the study personally collected all completed surveys.
Data Analysis
The researchers of the study developed a scoring system for the survey. General
questions (found on the demographic information page) and survey questions one, two,
three, four, and six were scored. Responses associated with inappropriate supplement
knowledge or use as determined by the literature review received a score of zero.
Responses demonstrating knowledge or use that was supported by the literature received
a score of one. A detailed description of the scoring system is found in Appendix G.
The percentage of respondents who answered each general question correctly was
reported in order to quantify the overall knowledge level of the population regarding
general supplement knowledge.

Mean scores for knowledge level and extent of provider discussion were
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calculated for each demographic group. Regression analysis was utilized to determine
whether a statistically significant correlation existed between each demographic group
and the level of knowledge. P values and R2 values were implemented to establish or
reject a relationship.
Regression analysis was also utilized to determine whether a relationship existed
between the knowledge score and extent of provider discussion. A respondent’s score
(out of five points) was one variable, while the second variable was the extent of their
discussion with a provider (out of four points). Because the highest score possible for
knowledge level was five, and the highest score possible for extent of provider discussion
was four, a one-point change was considered statistically meaningful.
Unpaired t tests were used to analyze mean differences and establish relationships
via P-values between knowledge levels and extent of provider discussion among different
demographic groups.
ANOVA (rather than regression analysis) was used to compare the means of
knowledge level as well as provider discussion scores in different age groups, as there
were more than two groups. The calculated P-values and confidence intervals assisted in
determining whether the difference across the age groups was statistically significant.
Reliability and Validity
Since all subjects received the same questionnaire, every measurement was
consistent and could be reproduced; it was therefore reliable. Similar questions were
reviewed for consistency of responses as a measure of survey reliability. Intrarater and
instrument reliability were not of concern, as the survey was standardized. However, as

interrater reliability relies on the respondent adhering to the task (fully completing the
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survey), this was effectively controlled by eliminating those surveys that were not
complete. A panel of reviewers evaluated the consent form, instructions, and survey for
readability, further enhancing the reliability of the survey instrument.
The study had adequate face validity, as user knowledge was being assessed and
analyzed, so the method (survey) was appropriate. Content validity was lacking, as the
survey utilized only a few questions and did not encompass all possible aspects of
supplement use. Some demographic data was collected, so some data was generalized,
allowing for population-related external validity. The survey sought to determine
supplement users’ level of knowledge and communication with providers. The theory that
levels of knowledge vary and may correlate with provider communication was made
based on various studies reviewed in the literature, therefore providing construct validity.
Dispensation of Data
The collected data was transferred to a hard drive and placed in the possession of
the Bethel University Physician Assistant Program research coordinator. The data will be
stored in a secure, locked space. Data will be destroyed in accordance with the policies of
the Physician Assistant Program.
Limitations and Delimitations
Limitations included sample size and applicability to the general population.
Willingness to participate limited the sample size. Another limitation was that the
gathered information could not be generalized to populations to which the survey was not
distributed. The survey was also sensitive to temporal threats, since it did not measure
past or future supplement use. The research also rendered limitations because data was

self-reported, meaning answers may have been fabricated due to the inability to recall
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circumstances related to supplement use or due to the desire to conceal truthful
information regarding supplement use. Further, many survey participants did not take all
supplements listed, so data was limited for less popular supplements. Illiteracy and
language barriers were also potential limitations.
A delimitation was that the results could not be generalized to urban populations
which are known to be diverse in terms of race, ethnicity, education levels, and
socioeconomic status. As the surveys were distributed in the outpatient laboratory of a
hospital and a bank, the study likely omitted certain minority populations, such as
homeless individuals. Also, as mentioned in the literature review, dietary supplement
consumers are often Caucasian, well-educated, and employed. Additionally, a large
proportion of supplement users are young to middle-age females. These biases were a
threat to the external validity of the study.
As the study evaluated use of only a select few supplements, a delimitation was
that the results were not applicable to all supplement users. Some respondent bias could
also have existed based on survey question interpretation.

Chapter Four: Results
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Introduction
Chapter four contains the results of data analysis. Data is organized according to
three main participant groups: gender, age, and education level. Descriptive statistics are
first provided for each of these groups regarding trends of supplement consumption. The
statistical analysis of the extent of their knowledge regarding supplement use is then
described in terms of mean scores; these have been normalized due to varying numbers of
supplements used by each responder. Mean scores for the extent of their discussion with
a provider are also presented. Finally, correlations are presented for each group regarding
their demographic information, knowledge level, and extent of provider discussion.
Calculations
The survey scoring system is described in detail in Appendix G. One point was
awarded for each of the general knowledge questions answered correctly, and the
maximum score for each supplement consumed was three. Therefore, the total possible
knowledge score was five. The total possible provider score was four.
Key terms utilized in this chapter include mean score and mean total score; the
mean total score is also reported in percentage form. The mean score for knowledge level
was calculated using only the supplement questions and thus did not take into account the
general knowledge questions. The value was calculated as the average score per
supplement as a means to normalize the data (over a denominator of three). The mean
total score incorporated general supplement knowledge (as assessed by the survey’s
“general supplement questions”) in addition to supplement knowledge applicable to all of
the supplements consumed by each participant. The value was also normalized (over a

denominator of five). The total score is also presented in percentage form as the total
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number of correct answers over the maximum number of points possible, depending on
the number of supplements taken. The percentage was calculated using the following
equation: [(total score + general question score)/(max score for supplements taken+2)] *
100.
Survey Population
Seventy-seven (77) surveys were collected, but 15 were rejected because they
were not complete. Some responders failed to supply demographic information, while
others failed to answer all of the survey questions about the supplements they took.
Therefore, data was analyzed using 62 qualified surveys. Of the 62 qualified participants,
49 (79.0%) were female, and 13 (21.0%) were male. Participants ranged from ages 18 to
over 61. The majority of participants were greater than 61 years of age (51 participants,
or 82.3%). One participant was 18-25 years of age (1.6%), two were 26-40 (3.2%), two
were 41-50 (3.2%), and six were 51-60 (9.7%). Also, the majority of participants’ highest
level of education was a high school graduate (41 participants, or 66.1%). Twenty-one
(33.9%) had either an associate’s or bachelor’s degree.
Population Description: Gender
The supplements analyzed in this study included vitamin D, fish oil, coenzyme
Q10, St. John’s wort, garlic, cinnamon, and magnesium. For each gender, all but one
participant used vitamin D (48/49 females and 12/13 males) (Figure 1). Fish oil was the
next most commonly used supplement, consumed by 28 (57%) females and 11 (84%)
males. In descending order of use behind vitamin D, female participants used coenzyme
Q10 and magnesium equally at 24% each (12/49). Twenty percent of females used

cinnamon (10/49), 14% used garlic (7/49), and St. John's wort was the least commonly

35

consumed supplement (6%, 3/49). Forty-six percent (6/13) of males used coenzyme Q10.
Cinnamon and magnesium were each consumed by 30% (4/13) of respondents. Garlic
was used by 23% (3/13), and St. Johns wort was consumed by eight percent (1/13).

Supplement Knowledge Based on Gender
The mean knowledge score per supplement was similar between both genders,
males scoring 1.25 (41.7%, StDev 0.75) and females 1.59 (53.0%, StDev 0.61). The
mean total knowledge score, including the general knowledge score, was 1.63 (over a
total of five) (31.2%, StDev 1.33) for males and 2.16 (43.6%, StDev 1.06) for females.
The mean score as a percentage for males was 35.3% (StDev 24) and females 46.0%
(StDev 19.6) (Figure 2).
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Provider Discussion Based on Gender
The maximum number of points for the provider score per supplement was four.
Among females, the mean score per supplement was 0.95 (StDev 0.7030); among males,
it was 0.89 (StDev 0.9419). The mean scores in percentage from, labeled as the provider
score (%), were 23.7% (StDev17.58) for females and 22.32% (StDev 23.55) for males
(Figure 2).
Correlations Based on Gender
Regression analysis using gender versus knowledge level revealed a P-value of
0.0925 (R2 4.64%) (Figure 3). A simple regression analysis studying provider discussion
score and knowledge level (%) yielded high P-values for each gender: female 0.1501 (R2
4.27%) and male 0.4820 (R2 5.06%).
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Population Description: Age
Responders were of limited age variation. The largest group of participants was
the >61 age group, which contained 51 respondents. The supplement use trend was
analyzed for the largest age group (>61); descending order is as follows: 96% used
vitamin D, 65% fish oil, 29% coenzyme Q10, 25% magnesium, 24% cinnamon, six
percent garlic, and six percent St. John's wort. Other age groups were difficult to analyze,
as there was limited data (Figure 4).
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Supplement Knowledge Based on Age
The mean knowledge score, over a maximum of three, for ages 18-25 was 2.0
(67%, StDev 0). The age 18-25 group contained only one participant. The second highest
average knowledge score was 1.57 (52.6%, StDev 0.43) among those in the 51-60 age
group; this group consisted of six participants. The average score for ages >61 was 1.54
(51.3%, StDev 0.66); this group consisted of 51 participants. The lowest average scores
were found in age groups 26-40 and 41-50. The average score in each of these groups
was 1.0 (33%); both groups consisted of two participants. Ages 26-40 had a standard
deviation of 1.4, while ages 41-50 had a standard deviation of 0.

The mean total score was calculated over a maximum of five. Values and

39

corresponding standard deviations can be found in Table 1. Calculated total knowledge in
percent can be found summarized with a graphical representation in Table 2 and Figure 5.

Provider Discussion Based on Age
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The maximum provider score per supplement was four. The average value for
each participant was calculated and used to calculate the average value for the
corresponding age group. The 18-25 age group did not score any points. The 26-40 age
group scored a mean of 0.33 (StDev 0.47), the 41-50 age group scored 1.50 (StDev 0.71),
the 51-60 age group scored 0.90 (StDev 0.70), and the > 61 age group scored 0.96 (StDev
0.76).
Percentage of correct provider responses was also calculated, and the means were
compared. Values can be found in Table 2 and graphical representation in Figure 6. As
seen in Figure 6, wide confidence intervals (CI) are observed in the 18-25, 26-40, and 4150 age groups and a narrow CI in the >61 age group. Additionally, a P-value of 0.41 was
produced.
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Correlations Based on Age
ANOVA was used to determine the differences in extent of knowledge among age
groups (Table 3 and Figure 7). A P-value was obtained for analysis of total knowledge
(P-value 0.74, R2 3.35%). To note is the wide CI for the 18-25, 26-40, and 41-50 age
groups and a narrow CI for the >61 age group.
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For each age group, the total knowledge score (%) was studied for possible
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correlation with the total provider score (%). As with knowledge score analysis, there
was insufficient data for the 18-25, 26-40, and 41-50 age groups. Regression analysis of
the 51-60 age group revealed a P-value of 0.27 and R2 of 28.91% (Figure 8). A higher Pvalue of 0.98 was obtained with the >61 age group, accompanied by an R2 of 0.00%
(Figure 9).
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Population Description: Education
Among the possible education categories, all participants were either in the high
school graduate (HS) or associate’s/bachelor’s degree (AS/BS) groups. Of the 62
participants, the majority (41, or 66%) were in the HS group; 21 (34%) were in the
AS/BS group.
Among HS graduates, 96% took vitamin D, 54% took fish oil, 27% took
coenzyme Q10, 27% took magnesium, 9.5% took cinnamon, 7.6% took garlic, and 3%
took St. John's wort. Among those who held AS/BS degrees, 95% took vitamin D, 81%
took fish oil, 74% took coenzyme Q10, 41% took magnesium, 33% took cinnamon, 10%
took garlic, and five percent took St. John's wort (Figure 10).
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In terms of reported use, both groups showed similar patterns of supplement use.
In order of decreased use: vitamin D, fish oil, coenzyme Q10, magnesium (at the same
frequency as coenzyme Q10 for HS graduates), cinnamon, garlic, and St. John's wort.

Supplement Knowledge Based on Education
The mean knowledge score over a maximum of three per supplement was 1.50
(StDev 0.62) for HS graduates and 1.55 (StDev 0.72) for AS/BS graduates. The mean
total knowledge score for the HS group was 1.99 (StDev 1.00), while AS/BS graduates
obtained a score of 2.17 (StDev1.37). The average total knowledge in percent for HS
graduates is 42.79% (StDev 18.35) and AS/BS 46.27% (StDev 25.61) (Figure 11).
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Provider Discussion Based on Education
The maximum score for provider discussion per supplement, written as provider
score, was four. High school graduates scored a mean of 1.04 (StDev 0.77) and AS/BS
graduates 0.73 (StDev 0.69). The provider score in percentage form was found to be
26.05% (StDev 19.24) for HS graduates and 18.34% (StDev 17.13) for AS/BS graduates
(Figure 11).
Correlations Based on Education
Analysis to determine whether a correlation existed between education levels and
total knowledge correct (%) revealed a P-value of 0.54 and R2 of 0.63%. To determine if
a correlation existed between provider discussion and knowledge level, a simple
regression analysis of HS provider score (%) and total knowledge level correct (%)
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revealed a P-value of 0.08 (R2 7.79%). As for the AS/BS graduates, regression analysis
yielded a P-value of 0.18 (R2 9.43%).

Additional Analysis
The first of the general knowledge questions received 18/62 (29.0%) correct
responses. Question two received 15/62 (24.2%) correct responses. The mean knowledge
level was calculated using all of the mean scores obtained in data analysis. The average
mean knowledge score was 1.52, the average total knowledge score was 2.05, and the
average total knowledge (%) was 43.97%. The average provider score was 0.94, and the
average provider score (%) was 23.44%
Further investigation was warranted regarding the provider score (%) and
knowledge level (%) in the >61 age group. As previously mentioned, 51 of the 62

participants were >61 years of age. Twelve of the 41 were male, and 29 were female.
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Both Figures 6 and 7 show narrow CI’s for this age group. Among females, the average
provider score (%) was 24.0 (StDev 17.74) and total knowledge (%) 48.38 (StDev
18.48). Among males, the mean provider score (%) was 24.18 (StDev 23.58) and total
knowledge (%) 22.67 (StDev 24.71). Regression analysis generated a P-value of 0.98,
suggesting a lack of correlation between the provider score (%) and gender in the >61 age
group. A correlation existed between knowledge level (%) and gender, at a P-value of
0.03 (Figure 13). The limited sample size for the other four age groups was the likely
cause for the wide CI’s. Thus, these age groups were considered unsuitable for further
study.

Summary
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In this chapter were the results of data analysis. Descriptive statistics were used to
analyze the population; these revealed a lack of variability across each demographic,
where 79% of responders were female, 82% were greater than 61 years of age, and 66%
were high school graduates. Correlation studies using regression analysis and ANOVA
were performed to determine whether relationships existed between demographics and
knowledge level as well as knowledge level and extent of discussion with a provider.
These studies revealed high P-values except in the case of the >61 age group, in which a
P-value of 0.03 was achieved when correlating gender and knowledge level (%). Due to
the small sample size in most demographic categories, analysis of provider discussion
and knowledge levels was difficult. Chapter 5 includes interpretation of all results noted
in Chapter 4 as well as conclusions based on those results.

Chapter Five: Discussion and Conclusions
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Introduction
Within this chapter are the conclusions drawn from the data analysis. Once again,
this project served to analyze supplement users’ knowledge levels and possible
correlations with demographics and provider discussion. For the purpose of the study,
knowledge is used as a blanket term to include correct understanding of regulation,
appropriate indications and dosages, as well as potential adverse effects of supplement
use. Additional terms were introduced in the data analysis so as to normalize and place
the values into a different perspective.
Demographic Data and General Knowledge
The average participant of this sample of 62 participants was a female over the
age of 61 whose highest level of education was a high school graduate. The majority of
responders were >61 years of age (51/62 participants). This population was not the result
of random sampling; rather, the surveys were distributed to people over age 60 due to
convenience and accessibility of that population through Dakota Community Bank. None
of the responders had higher than a bachelor’s degree. Although employment status was
not assessed, the population findings in this study did not agree with those reported by
Bailey (Bailey et al., 2013), who found the average American supplement consumer was
a young to middle-aged, well-educated, employed individual. However, the survey was
distributed primarily to adults >61 years of age, which could explain the discrepancy
between this study and previous studies.

The most commonly used supplement was vitamin D, followed by fish oil.
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Coenzyme Q10, cinnamon, and magnesium were less frequently used, and garlic and St.
John’s wort were the least commonly consumed supplements.
The majority of participants (71%) were not aware that the FDA does not test
dietary supplements for safety and efficacy. A previous study also noted that the majority
(52%) of responders were unaware that the FDA did not test supplements for safety or
efficacy (Ashar & Rowland, 2008). Further, most participants (75.8%) did not believe
that a supplement with the USP seal was superior to a supplement without such seal.
Thus, among the supplement users surveyed, a deficit of knowledge regarding the
regulation of dietary supplements was apparent.
Supplement Users’ Knowledge Level
The first research question addressed in the study was the following: To what
degree, if any, are supplement users knowledgeable regarding the regulation, appropriate
indications and dosages (as determined by literature review), and potential adverse effects
of dietary supplement use?
The mean total knowledge scores (%) were similar among males (35.3%) and
females (46.0%). Thus, taking into account all of the factors assessed by the survey, the
extent of knowledge among both males and females was less than 50%.
Knowledge scores did not follow any trend in terms of age, as the highest score
was in the youngest age group (which consisted of only one participant), but the lowest
scores were found in the middle age groups. Calculated knowledge levels in each age
group varied from 26.1% to 54.5%, meaning the extent of knowledge was again <50%,
with the exception of the 18-25 age group, for which it was still low (<60%). Regarding

knowledge level and education, the AS/BS group scored higher than those in the HS
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group. However, both groups again achieved a <50% knowledge score, with the HS
group at 42.8% and the AS/BS group at 46.3%. Therefore, it appeared that education
level did not have a significant effect on the level of participant knowledge.
In assessing knowledge of the overall population surveyed (the mean scores of all
demographic groups), the mean knowledge score was 1.52, the mean total knowledge
score was 2.05, and the total knowledge (%) was 43.97%. Though the data analysis in the
study presented total knowledge scores rather than scores regarding specific aspects of
knowledge, the results were in accordance with previous studies that reported a lack of
knowledge regarding supplement use. A study by Bailey (Bailey et al., 2013) reported
only 22% of supplement users cited nutritional deficiency as their primary indication for
supplement use. Further, Kaufman et al. (2002) reported a small percentage of consumers
did not know why they took supplements. Another study (Marinac et al., 2007) concluded
that 66% of people believed that dietary supplements “pose no risk to the general
population,” indicating a lack of knowledge regarding potential drug interactions (12
responders in that study had potential drug interactions with the supplements they took).
Thus, the overall knowledge score of <50% correlated with a similar lack of knowledge
found in previous studies.
Correlation of Demographic Data and Supplement Knowledge
The research question addressed in this section is the following: What
relationship, if any, exists between supplement users’ demographic data and their
knowledge of the aforementioned factors?

The numerical value used to evaluate knowledge level was the total knowledge
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percent score; this was compared with demographic data. Across the demographic
groups, regression analysis yielded high P-values. With gender, the null hypothesis could
not be rejected, signifying a lack of relationship between gender and knowledge level, at
a P-value of 0.09. Similarly, the level of education did not appear to be a predictor of
knowledge level, where the P-value was 0.54. ANOVA analysis among the age
categories produced a P-value of 0.744, so the difference in means was not statistically
significant. Wide 95% confidence intervals (CI) were also found with the 18-25, 26-40,
and 41-50 age groups, where the CI’s overlapped, signifying no significant difference.
Improved certainty was noted with the >61 age group due to the tighter CI, but once
again, age alone did not appear to be correlated with knowledge level. Reviewing the
literature, the researchers of the study did not find previous studies that attempted to
correlate demographic data with level of knowledge of dietary supplements; therefore, no
comparisons could be made to findings of previous studies.
Supplement Users’ Discussion with Provider
The following research question is addressed in this section: To what extent, if
any, do supplement users discuss their dietary supplement use with healthcare providers?
Key points in the provider discussion, if such an event occurred, included
discussion about indications, dosages, and possible drug interactions. Overall, the extent
of supplement discussion with providers was low, where the average provider score per
supplement was 0.94 over a maximum of four points, and the average score in percent
was 23.44%. Among genders, the mean score was similar, and the scores in percentage
were within about one percent of that of the general population. In terms of education,

there was more variation. High school graduates scored 1.04 and 26.05%, while the
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AS/BS group scored 0.73 and 18.34%. Based on these numbers, HS graduates appeared
to discuss more with providers than AS/BS graduates, but there is minimal deviation
from the overall population scores. Across the age groups, there was more variability, in
which the lowest score was 0.00 with a provider percent score at 0% in the 18-25 age
group, and the highest score was 1.50 and 37.5% in the 41-50 age group. ANOVA
analysis produced a P-value of 0.41, indicating that the difference in values across all age
groups was not statistically significant. The analysis also reported wide 95% confidence
intervals (CI) for the 18-25, 26-40, and 41-50 age groups, so there was less certainty
concerning the mean as opposed to the tighter CI with the >61 age group.
The overall low provider score (0.94/4) correlated with previous studies regarding
discussion of supplement use with providers. One previous study concluded 77% of
dietary supplement consumers used supplements by personal choice rather than due to the
advice of their healthcare provider (Bailey et al., 2013). In another survey (Eisenberg et
al., 2001), over half of patients either did not believe it was important for their physician
to know of their supplement use or reported that their physician never asked. Another
previous study of primary care physicians (Tarn et al., 2014) also noted a lack of patientprovider discussion. In that study, of all conversations regarding supplement use in the
office, only 28% included how to take the supplement, 17% discussed potential risks, and
17% discussed efficacy. Included in the overall provider score for the study was a
question regarding dosage. A previous study performed by Thompson and Nichter
revealed 23% of consumers tailored their supplement regimens experimentally or viewed
the suggested dosages on the labels as general guidelines (Thomspon & Nichter, 2007).

Though this study did not present data regarding specific aspects of supplement use
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discussed with a provider, the results correlated with these previous studies, which noted
an overall lack of patient-provider discussion regarding dietary supplement use.
Correlation of Knowledge Level with Provider Discussion
The following research question is addressed in this section: What relationship, if
any, exists between supplement users’ level of knowledge regarding dietary supplements
and their extent of discussion of dietary supplements with healthcare providers?
High P-values were obtained in studying the correlation of knowledge level (%)
and provider discussion among males (0.4820) and females (0.1501). P-values obtained
from correlation studies between knowledge level (%) and provider discussion were only
presented for two age groups (51-60 and >61), as there was insufficient data to obtain Pvalues from other age groups. Analysis of the 51-60 age group revealed a P-value of 0.27,
while a higher P-value of 0.98 was obtained with the >61 age group. Finally, analysis of
the education demographic revealed P-values of 0.08 for the HS group and 0.18 for the
AS/BS group. Due to these high P-values, no correlations were found between
knowledge level and extent of provider discussion for any of the demographic groups
studied. Again, the researchers of the study did not find previous studies regarding the
correlation of knowledge level with extent of provider discussion, so these results could
not be compared with results of previous studies.
Additional Analysis
ANOVA analysis of provider score (%) and total knowledge (%) of the >61 age
group revealed a tight confidence interval. An unpaired t-test revealed a correlation
between gender and total knowledge (%) in this age group, with a P-value of 0.03;

56

however, no correlation was found between gender and provider score (%). Gender and
age, then, were predictors of total knowledge (%), where females over the age of 61
(n=38) were associated with a higher knowledge level. As other age groups had limited
sample size and therefore high variability with overlapping CI’s, there was likely no
significant difference, so no further analysis was conducted.
Limitations
In scoring the surveys, the researchers found significant inconsistency among
many supplement users. Though all supplements have the potential for harmful side
effects and drug interactions, those who used more than one supplement commonly
reported that some supplements they consumed, but not others, had the aforementioned

dangers. Overall correct responses to each survey question could therefore not be tallied
and reported in percentage form, due to the variability in each responder’s survey
answers.
The results of the study cannot be easily applied to all supplement users, as the
sample size was small, and the population consisted almost entirely of one demographic
group. In comparing means, a minimum sample size of 50 per category analyzed would
reveal a more accurate average, while 100 would be ideal. The only category studied that
met this minimum was the >61 age group.
Another limitation of the study was that the researchers did not include a
demographic option for those participants who did not earn a high school degree; high
school graduate was the lowest level of education presented as a choice on the survey.
Some participants did not choose a level of education, perhaps for this reason, and
therefore were eliminated from analysis.

Recommendations for Further Research
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If this study were repeated, the researchers recommend a larger sample size
consisting of more varied demographic groups. Ideally, each demographic group would
have approximately the same number of participants to avoid results that are weighted
toward one specific population.
Further research regarding dietary supplements should focus on one supplement
or general supplement knowledge rather than multiple, specific supplements. The survey
was broad, and the sample size for those taking some supplements, such as St. John’s
wort, was small. Further, many potential participants refused to take the survey because
they reported it was too lengthy. A shorter, more concise survey may yield a larger
sample size.
Conclusions
Based on the available data, supplement users have a <50% knowledge level
regarding all aspects of supplement use analyzed with the survey instrument. No
significant relationship was found between supplement users’ demographic data and their
level of knowledge aside from females >61 years of age. Females >61 had a greater level
of knowledge, but again due to the small sample size, further study is warranted to
validate this relationship. The extent of participants’ discussion of supplement use with a
provider was minimal, where most provider scoring values hovered at 25% or less for the
majority of demographic categories. Finally, among all groups surveyed, there appeared
to be no significant correlation between their level of knowledge and their extent of
discussion with a provider; this was expected, however, as both their knowledge level
and extent of provider discussion were minimal.
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In scoring the surveys, the inconsistent responses regarding different supplements
taken by a single responder revealed that supplement consumers may be more
knowledgeable regarding one supplement than another. Further data analysis could seek
to correlate knowledge level regarding a single supplement with provider discussion.
Further research could seek to determine the reason for the inconsistencies.
The sample size was small, and most of the data analyzed was from a single
population of supplement users, namely those >61 years of age. Little data was available
from other age groups and across varying levels of education, so the data regarding other
demographics is less significant. Therefore, in repeating this study, an effort should be
made to garner a larger population and perhaps focus on one commonly used supplement
rather than multiple supplements at once.
Because the researchers developed a novel survey instrument, some aspects of
this study could not be directly related to previous studies. Literature review did not

reveal previous studies that sought to correlate demographic data with knowledge level or
knowledge level with provider communication. Further, the data analysis for this study
resulted in overall knowledge scores rather than individual scores for each aspect of
supplement knowledge and discussion analyzed. Overall knowledge scores were obtained
due to the varied responses for each supplement taken by a single survey respondent.
However, overall analysis correlated with previous studies that revealed a lack of
knowledge regarding supplement regulation, appropriate indications and dosages, and
potential adverse effects. The study also correlated with previous studies that noted a lack
of discussion with a healthcare provider regarding dietary supplement use.
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SURVEY CONSENT FORM
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You are invited to participate in a study of dietary supplement use. The researchers
of this study hope to learn information about the knowledge level and practices of
persons who currently use dietary supplements. This research is being conducted
by students pursuing a Master’s of Physician Assistant Studies degree at Bethel
University in Saint Paul, Minnesota. This research is required for completion of the
Master’s program. No funding agency is involved in this research.

Participation in this study is voluntary. If you choose to participate, you will be
asked to complete a survey regarding certain dietary supplements. You must
currently take one or more of the supplements listed on the instructions page (page
2) in order to participate. The survey will take approximately 15 minutes to
complete.

Your decision whether or not to participate will not affect your future relations with
CHI Saint Alexius Health or Bethel University in any way. If you decide to
participate, you are free to discontinue participation at any time.
There are no risks associated with participation in this study, and confidentiality
will be maintained. No identifying information will be collected. Only authorized
research personnel will review survey responses.

This research project has been reviewed and approved in accordance with Bethel
University’s Levels of Review for Research with Humans. It has been reviewed at the
appropriate level and is in accordance with federal guidelines and ethical principles.
The CHI Saint Alexius Health Institutional Review Board has also reviewed and
approved this research project. If you have any questions about the research and/or
research participants’ rights, please call Sarah Kucera (701-391-5177) or Yen
Nguyen (612-462-5734).

By proceeding with this study, you are agreeing that you are at least 18 years of age.
You are also acknowledging your understanding of the terms of your participation
in this study as described above and agree to participate based on those terms. You
may withdraw at any time should you choose to discontinue participation in this
study.
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SURVEY INSTRUCTIONS

69

1. Please read each question carefully before responding.

2. Please record responses only for the supplements you currently use. Each page
of the survey is to be completed only if you currently take the supplement listed at
the top of that particular page. If you do not take the supplement named at the top of
the page, please skip that page.
3. The supplements in this study include the following:
• Vitamin D
• Fish oil
• Coenzyme Q10 (CoQ10)
• St. John’s Wort
• Garlic
• Cinnamon
• Magnesium

If you do not currently use one of these supplements, you are not eligible to
take this survey.
4. Please respond to all survey questions. Please do not guess the correct response,
but rather choose “UNKNOWN” if you do not know the answer.
5. Demographic information (next page) must also be supplied.
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DEMOGRAPHIC INFORMATION
Please check the option that best describes you.
Gender
☐Male
☐Female

Age
☐18-25
☐26-40
☐41-50
☐51-60
☐60+

Highest Level of Education Completed
☐High school graduate OR some college
☐Associate’s degree OR Bachelor’s degree
☐Master’s degree OR Doctoral degree

GENERAL SUPPLEMENT QUESTIONS

Answer these if you currently take ANY of the dietary supplements listed on
the instructions page (page 2).
1. Does the FDA (Food and Drug Administration) test
dietary supplements for safety and efficacy (whether
they work)?

☐UNKNOWN
☐YES
☐NO

2. Is a supplement with the USP (United States
Pharmacopeia) seal in any way better than a supplement
with no such seal?

☐UNKNOWN
☐YES
☐NO

APPENDIX C
Survey Instrument
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ADDENDUM TO DIETARY SUPPLEMENTS: A CONSUMER PROFILE OF
KNOWLEDGE AND USE
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Study Site and Population
The surveys will be distributed at an additional site due to lack of patient
participation at the CHI St. Alexius Health outpatient laboratory. The researchers have
secured an affiliation with Dakota Community Bank and Trust in Bismarck, North
Dakota. The surveys will be distributed by the “Good Neighbor Loyalty Club”
representatives employed by Dakota Community Bank and Trust. The surveys will be
dispensed to senior travel club members during a bus trip the week of May 16 through
May 20, 2016. A sample size of 40 is desired. Data collection will persist beyond May
20, 2016, if an adequate sample size is not achieved by that date. If this is required,
employees of Dakota Community Bank and Trust will distribute surveys to customers as
time permits. The researchers of this study will personally collect the completed surveys.
A letter of intent for research affiliation with Dakota Community Bank and Trust can be
found below.

APPENDIX G
Survey Scoring System
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The demographic information will not be scored in any way.
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General questions:

Does the FDA (Food and Drug Administration) test dietary supplements for
safety and efficacy (whether they work)?
o
o

A score of “0” will be given if the subject responds “unknown” or “yes.”
A score of “1” will be given if the subject responds “no.”

Is a supplement with the USP (United States Pharmacopeia) seal in any way
better than a supplement with no such seal?
o
o

A score of “0” will be given if the subject responds “unknown” or “no.”
A score of “1” will be given if the subject responds “yes.”

The following questions are applied to each of the surveyed supplements: Vitamin
D, fish oil, Co-Q10, garlic, St. John’s wort, cinnamon, and magnesium. The scoring

will be based on whether the subjects choose appropriate indications supported by
the literature.

Question 1. Is there any potential for harmful side effects with the
consumption of this supplement?
o
o

A score of “0” will be given if the subject chooses “unknown” or “no.”
A score of “1” will be given if the subject chooses “yes.”

Question 2. Is it safe to take this supplement with any prescription drug?
o
o

A score of “0” will be given if the subject chooses “unknown” or “yes.”
A score of “1” will be given if the subject chooses “no.”

Question 3. Why did you start taking this supplement? Check all that apply.
o
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A score of “0” will be given if the subject chooses indications that are
not supported by the literature or if the respondent chooses “I don’t

o

know.”

A score of “1” will be given if the subject chooses indications
supported by the literature.

Question 4. How do you decide the dose (how much to take) of this
supplement?
o

o

A score of “0” will be given if the subject chooses “I decide the dose
myself.”

A score of “1” will be given if the subject chooses “label” or “provider.”

Question 5 will not be scored.

Question 6. If you have discussed this supplement use with a healthcare
provider, which of the following did you discuss? Check all that apply.
o
o

A score of “0” will be given for “not applicable.”

A score of “1” will be given for each aspect discussed.

APPENDIX H
IRB Approval
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February 18, 2016

89

Sarah & Yen;
As granted by the Bethel University Human Subjects committee as the program director, I write this
letter to you in approval of Level 3 Bethel IRB of your project entitled: "Dietary Supplements: A
Consumer Profile of Knowledge and Use." This approval is good for one year from today's date. You
may proceed with data collection and analysis. Please let me know if you have any questions."
Sincerely;
Wallace Boeve, EdD, PA-C
Program Director
Physician Assistant Program
Bethel University
w-boeve@bethel.edu
651 308-1398 cell
651 635-1013 office
651 635-8039 fax
http://gs.bethel.edu/academics/masters/physician-assistant

